ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMeds key product, Personalized Prediction Profile, has been used by board-certified veterinary oncologists, helping over 5,000 dogs with lymphoma and leukemia. With ImpriMeds services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach to cancer care has been published in a scientific journal and presented at major conferences and is supported by over 350 veterinary oncologists at 200+ specialty hospitals in the US.
For more information, visit their website https://www.imprimedicine.com/